NasdaqGM - Nasdaq Real Time Price USD

IRADIMED CORPORATION (IRMD)

Compare
57.52
+1.01
+(1.79%)
At close: 4:00:00 PM EST
57.52
0.00
(0.00%)
After hours: 4:02:28 PM EST
Loading Chart for IRMD
DELL
  • Previous Close 56.51
  • Open 56.91
  • Bid 56.93 x 100
  • Ask 58.19 x 100
  • Day's Range 56.10 - 57.99
  • 52 Week Range 40.18 - 58.41
  • Volume 28,157
  • Avg. Volume 40,045
  • Market Cap (intraday) 728.974M
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 39.40
  • EPS (TTM) 1.46
  • Earnings Date Feb 6, 2025 - Feb 10, 2025
  • Forward Dividend & Yield 0.60 (1.06%)
  • Ex-Dividend Date Nov 15, 2024
  • 1y Target Est 65.00

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

www.iradimed.com

148

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IRMD

View More

Performance Overview: IRMD

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

IRMD
4.41%
S&P 500
1.08%

1-Year Return

IRMD
28.21%
S&P 500
22.14%

3-Year Return

IRMD
36.97%
S&P 500
25.41%

5-Year Return

IRMD
146.09%
S&P 500
77.70%

Compare To: IRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IRMD

View More

Valuation Measures

Annual
As of 1/13/2025
  • Market Cap

    716.18M

  • Enterprise Value

    664.72M

  • Trailing P/E

    38.71

  • Forward P/E

    32.89

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.11

  • Price/Book (mrq)

    8.58

  • Enterprise Value/Revenue

    9.32

  • Enterprise Value/EBITDA

    30.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.12%

  • Return on Assets (ttm)

    14.67%

  • Return on Equity (ttm)

    23.58%

  • Revenue (ttm)

    71.31M

  • Net Income Avi to Common (ttm)

    18.63M

  • Diluted EPS (ttm)

    1.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.72M

  • Total Debt/Equity (mrq)

    0.32%

  • Levered Free Cash Flow (ttm)

    13.14M

Research Analysis: IRMD

View More

Company Insights: IRMD

Research Reports: IRMD

View More

People Also Watch